| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/31/2006 | US7129207 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 10/31/2006 | US7129084 Production of humanized antibodies in transgenic animals |
| 10/31/2006 | US7129078 DNA encoding androgen receptor fragment |
| 10/31/2006 | US7129060 Export systems for recombinant proteins |
| 10/31/2006 | US7129057 Human testis specific serine/threonine kinase 3 |
| 10/31/2006 | US7129056 Detecting circulating epithelial cancer cells in anticoagulated whole blood sample by using special transparent container, mixing sample with epitope labeling agents/cell morphology stains, centrifuging, and inspecting |
| 10/31/2006 | US7129055 Detection of translocation protein in sample; obtain tissue sample, incubate with binding agent, detect binding activity, presence of bound agent indicates presence of translocation protein |
| 10/31/2006 | US7129054 DNA sequences which code for new members of the TGF- beta protein family with mitogenic and/or differentiation-inductive potential |
| 10/31/2006 | US7129053 Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool |
| 10/31/2006 | US7128912 Fibronectin binding protein compositions and methods of use |
| 10/31/2006 | US7128911 Virus-like particle, and an antigen or antigenic determinant of a receptor activator factor kappa beta ligand protein, fragment or peptide |
| 10/31/2006 | US7128910 Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequences and uses thereof |
| 10/31/2006 | US7128908 Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof |
| 10/31/2006 | US7128907 Methods of treating crohn's disease with anti-TNF antibodies |
| 10/31/2006 | US7128905 methods of preventing and treating diseases wherein the involvement of apoptosis has been indicated. |
| 10/31/2006 | US7128875 Signal processing devices comprising biological and bio-mimetic components |
| 10/31/2006 | CA2336561C Monoclonal antibody to lymphocyte-associated cell surface protein |
| 10/31/2006 | CA2332183C Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 10/31/2006 | CA2250047C Monoclonal antibodies binding human growth hormone (hgh) |
| 10/31/2006 | CA2180830C Anti-annexin-v monoclonal antibody, process for producing the same, and use thereof |
| 10/31/2006 | CA2129733C Mammalian expression systems for hcv proteins |
| 10/27/2006 | CA2562567A1 Acethylcholinesterase(ache) variants of the n-terminus |
| 10/26/2006 | WO2006113643A2 High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies |
| 10/26/2006 | WO2006113623A2 Elimination of heterogeneous or mixed cell population in tumors |
| 10/26/2006 | WO2006113522A2 Methods of detecting hepatitis c virus |
| 10/26/2006 | WO2006113402A1 Methods and compositions for modulating and detecting wisp activity |
| 10/26/2006 | WO2006113331A1 Methods for treating and preventing fibrosis by il-21 / il-21r antagonists |
| 10/26/2006 | WO2006113308A1 Method for treating inflammatory bowel disease (ibd) by an anti-cd20 antibody |
| 10/26/2006 | WO2006113139A2 Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| 10/26/2006 | WO2006112933A1 Antibodies and related molecules that bind to psca proteins |
| 10/26/2006 | WO2006112838A1 Stabilized anti-hepatitis b (hbv) antibody formulations |
| 10/26/2006 | WO2006112738A1 Novel peptides and methods for the treatment of inflammatory disorders |
| 10/26/2006 | WO2006112400A1 Method of examining metastatic property and infiltration ability of cancer |
| 10/26/2006 | WO2006112238A1 Gene capable of controlling differentiation/growth of plant, and use of the same |
| 10/26/2006 | WO2006112040A1 NOVEL β-GALACOTSIDE-α-2,3-SIALYLTRANSFERASE, GENE ENCODING THE SAME AND METHOD OF PRODUCING THE SAME |
| 10/26/2006 | WO2006112025A1 NOVEL β-GALACTOSIDE-α-2,3-SIALYLTRANSFERASE, GENE ENCODING THE SAME AND METHOD FOR PRODUCING THE SAME |
| 10/26/2006 | WO2006111776A2 Pharmaceutical composition comprising serum obtained from a naive mammal |
| 10/26/2006 | WO2006111616A1 Peptide vaccine for influenza virus |
| 10/26/2006 | WO2006111372A2 Phytase |
| 10/26/2006 | WO2006073921A3 Compositions and methods for enhanced dendritic cell maturation and function |
| 10/26/2006 | WO2006022882A3 Canine pancreatic lipse |
| 10/26/2006 | WO2005124352B1 Method for determining aggrecanase activities |
| 10/26/2006 | WO2005067980A3 Design of therapeutics and therapeutics |
| 10/26/2006 | WO2005062788A3 Prostate specific proteins expressed in cancer and methods of use thereof |
| 10/26/2006 | WO2005054427A3 Target sequences for synthetic molecules |
| 10/26/2006 | WO2005011599A3 Antibodies specific for toxic amyloid beta protein oligomers |
| 10/26/2006 | WO2002101008A3 Intracellular signaling molecules |
| 10/26/2006 | US20060242721 Gene families associated with liver cancer |
| 10/26/2006 | US20060241291 Purified antibody, monoclonal antibody, or polyclonal antibody that binds to DES protein of Mycobacterium tuberculosis; medical diagnosis |
| 10/26/2006 | US20060241290 recombinant or monoclonal antibodies comprising the antigen-binding fragments specific for polypeptides, used for treating the effects of stroke, hypoxia and/or ischemia |
| 10/26/2006 | US20060241289 Antibody for the thyrotropin receptor and uses thereof |
| 10/26/2006 | US20060241288 Extracellular aspergillus polypeptides |
| 10/26/2006 | US20060241285 Crystals and structure of Synagis Fab |
| 10/26/2006 | US20060241284 Transmembrane protein amigo and uses thereof |
| 10/26/2006 | US20060241281 Peptidomimetic polymers for antifouling surfaces |
| 10/26/2006 | US20060241139 Treatment of DNA damage related disorders |
| 10/26/2006 | US20060241036 Soluble human interleukin 18 receptor-alpha, method of assaying the same, assay kit and medicinal composition |
| 10/26/2006 | US20060240570 Cobalamin assay |
| 10/26/2006 | US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity |
| 10/26/2006 | US20060240519 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 10/26/2006 | US20060240517 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240496 Immunogens, derivatives and immunoassay for ethyl glucuronide |
| 10/26/2006 | US20060240491 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 10/26/2006 | US20060240484 Protein for diagnosing diabetic retinopathy |
| 10/26/2006 | US20060240483 Inducing signalosome formation in cells, lysing and incubating the cell lysate on a solid phase coated with antibody capable of capturing the receptor within the signalosome, separating solid phase from the cell lysate, and detecting and measuring the amount of the protein bound to the solid phase |
| 10/26/2006 | US20060240476 Thrombotic thrombocytopenic purpura (TTP); epitope recognized by an antibody (anti-ADAMTS-13 antibody) against a cleaving protease ( ADAMTS-13) specific to von Willebrand factor |
| 10/26/2006 | US20060240470 Gene causative of Rothmund-Thomson syndrome and gene product |
| 10/26/2006 | US20060240465 CNG2B: a novel human cyclic nucleotide-gated ion channel |
| 10/26/2006 | US20060240432 Transmembrane serine protease probes for use as evaluative tool in detection of nervous system stem cells and treatment of neurodegenerative diseases; regenerative medicine; tissue engineering |
| 10/26/2006 | US20060240425 Genes and polypeptides relating to myeloid leukemia |
| 10/26/2006 | US20060240415 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 10/26/2006 | US20060240414 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 10/26/2006 | US20060240036 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis |
| 10/26/2006 | US20060240035 Vmp-like sequences of pathogenic borrelia species and strains |
| 10/26/2006 | US20060240029 Chlamydia pneumoniae antigens |
| 10/26/2006 | US20060240028 Anti-nls substances and uses thereof in nuclear import inhibition |
| 10/26/2006 | US20060240027 Conjugated with toxins, enzymes, radioactive compounds, and hematogenous cells; use in staging and diagnosis; treatment of metastasis |
| 10/26/2006 | US20060240025 isolated polypeptide encoded by an isolated nucleic acid molecule as antitumor biodrugs; modulation of chemokine, cytokine expression |
| 10/26/2006 | US20060240024 T cell regulation |
| 10/26/2006 | US20060240023 Apoptosis-associated protein and use thereof |
| 10/26/2006 | US20060240021 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes |
| 10/26/2006 | US20060240020 Inhibition of complement activation |
| 10/26/2006 | US20060240019 Antagonists of HMG1 for treating inflammatory conditions |
| 10/26/2006 | US20060240018 Artificial antibody polypeptides |
| 10/26/2006 | US20060240017 IgG4 constant region; antigen-binding Fab' fragment; antibody or antigen binding fragment competitively inhibits binding of A2 to human TNF- alpha , and binds to a neutralizing epitope of human TNF- alpha |
| 10/26/2006 | US20060240015 Recombinant antibody against human insulin-like growth factor |
| 10/26/2006 | US20060240012 For treating inflammation and immunopathy; rheumatoid arthritis |
| 10/26/2006 | US20060240010 Methods of modulating CD200 receptors |
| 10/26/2006 | US20060240008 Therapy of autoimmune disease in a patient with an inadequate response to a TNF-alpha inhibitor |
| 10/26/2006 | US20060240006 Novel antibody structures derived from human germline sequences |
| 10/26/2006 | US20060240004 Methods for treating tweak-related conditions |
| 10/26/2006 | US20060240003 Humanised antibodies to the epidermal growth factor receptor |
| 10/26/2006 | US20060240002 Methods of inhibiting angiogenesis-dependent conditions mediated by cryptic epitopes of extracellular matrix components |
| 10/26/2006 | US20060240001 Modulation of P-cadherin mediated adhesion and intracellular signaling is expected to result in decreased proliferation and survival of tumor cells in vivo |
| 10/26/2006 | US20060239998 Prevention, treatment or reduction of bleeding disorders of hemophilia patients with inhibitory antibody against the C2 domain of Factor VIII; antihemophilic factor inhibitors; monoclonal cell lines expressing such anti-idiotypic antibodies; monoclonal cell lines expressing such anti-idiotypic antibodies |
| 10/26/2006 | US20060239997 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 10/26/2006 | US20060239996 ANTIBODIES SPECIFIC FOR UNGULATE PrP |
| 10/26/2006 | US20060239991 polypeptide has the biological activity of methionyl tRNA synthetase; for the protection against bacterial infections |
| 10/26/2006 | US20060239978 Cellular expression of 65B13 in the neurons can be used as an index to select cells that are suitable in terms of their safety, survival rate, and network formation ability, for transplant therapy of neurodegenerative diseases such as Parkinson's disease |